Back
DXP Enterprises Vs. Novo Nordisk AS Industry Stock Comparison
Buy
75
DXPE
DXP Enterprises
Last Price:
$84.32
Seasonality Move:
9.51%
Sell
11
NONOF
Novo Nordisk AS
Last Price:
$87.12
Seasonality Move:
8.64%
Buy
75
DXP Enterprises (DXPE)
is a Buy
Is DXP Enterprises a Buy, Sell or Hold?
-
The current DXP Enterprises [DXPE] share price is $84.39. The Score for DXPE is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
-
DXPE is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
11
Novo Nordisk AS (NONOF)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NONOF] share price is $87.12. The Score for NONOF is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
-
NONOF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
DXPE Stock Price Chart
What is DXP Enterprises's stock price today?
-
The DXP Enterprises share price today is $84.39Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DXPE is experiencing slight buying pressure.
NONOF Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $87.12Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing slight selling pressure.
DXPE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.5 | Buy |
Relative Strength Index (14 RSI): | 74.95 | Buy |
Chaikin Money Flow: | 24451 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (75.02 - 81.96) | Buy |
Bollinger Bands (100): | (48.53 - 72.99) | Buy |
NONOF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -6.17 | Sell |
Relative Strength Index (14 RSI): | 32.19 | Sell |
Chaikin Money Flow: | -1350 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (91.04 - 111.82) | Sell |
Bollinger Bands (100): | (102.11 - 130.43) | Sell |
DXPE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 81.9 | Buy |
20-day SMA: | 79.79 | Buy |
50-day SMA: | 69.89 | Buy |
200-day SMA: | 55.5 | Buy |
8-day EMA: | 82.09 | Buy |
20-day EMA: | 79.27 | Buy |
50-day EMA: | 71.98 | Buy |
200-day EMA: | 56.61 | Buy |
NONOF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 86.63 | Buy |
20-day SMA: | 99.79 | Sell |
50-day SMA: | 104.86 | Sell |
200-day SMA: | 124.53 | Sell |
8-day EMA: | 89.41 | Sell |
20-day EMA: | 96.18 | Sell |
50-day EMA: | 104.4 | Sell |
200-day EMA: | 115.91 | Sell |
DXP Enterprises Earnings Growth & DXPE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.24 per share, and an increase next year of $0.64 per share.
Novo Nordisk AS Earnings Growth & NONOF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and a decrease next year of $0.00 per share.
DXP Enterprises Technical Analysis
Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
18 | 19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
18 | 19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |